Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amin, M.
Right arrow Articles by Elhendy, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amin, M.
Right arrow Articles by Elhendy, A.
(Chest. 2003;124:2093-2097.)
© 2003 American College of Chest Physicians

Pulmonary Hypertension in Patients With Chronic Renal Failure*

Role of Parathyroid Hormone and Pulmonary Artery Calcifications

Mona Amin, MD; Ashraf Fawzy, MD; Magdy Abdel Hamid, MD and Abdou Elhendy, MD, PhD

* From the Departments of Internal Medicine (Dr. Amin), Nuclear Medicine (Dr. Fawzy), and Cardiology (Dr. Hamid), Cairo University Hospital, Cairo, Egypt; and Department of Internal Medicine, Section of Cardiology, University of Nebraska Medical Center (Dr. Elhendy), Omaha, NE.

Correspondence to: Abdou Elhendy MD, PhD, 982055 Nebraska Medical Center, Omaha, NE 68198-2265; e-mail: Aelhendy{at}unmc.edu

Rationale: The aim of this work was to study the association of pulmonary hypertension (PH) with pulmonary artery calcifications (PACs) and hyperparathyroidism in patients with chronic renal failure (CRF) receiving regular hemodialysis.

Background: Scarce data are available regarding the prevalence and the predictors of PH in patients with CRF. Abnormal 99mTc diphosphonate lung uptake was reported in these patients, suggesting a role of PACs.

Methods: We studied 51 patients (28 men and 23 women) with end-stage renal disease, who were receiving regular hemodialysis. Patients underwent two-dimensional, Doppler echocardiographic imaging. Laboratory investigations included BUN, serum creatinine, calcium, phosphorus, alkaline phosphatase, and intact molecule parathormone. PH was defined as pulmonary artery systolic pressure > 35 mm Hg as determined by Doppler echocardiographic evaluation.

Results: PH was detected in 15 patients (29%). Women had a higher prevalence of PH (48% vs 14%, p = 0.01). There was no significant differences between patients with PH and those without PH with regards to age, duration of dialysis, serum calcium (9.6 ± 2 mg/dL vs 10 ± 2 mg/dL), phosphorus (6 ± 1.4 mg/L vs 6.2 ± 1.9 mg/L), alkaline phosphatase (609 ± 768 U/L vs 473 ± 574 U/L), parathyroid hormone (PTH) [420 ± 512 pg/mL vs 354 ± 519 pg/mL] or the prevalence of an abnormal 99mTc diphosphate lung scan result (60% vs 73%, respectively [± SD]).

Conclusions: This study demonstrated that 29% of patients with CRF receiving regular hemodialysis have PH. The presence of PH was not related to the level of PTH or the severity of other metabolic abnormalities. There was no relation between PH and the presence or the severity of PAC. PH is detected more frequently in women. This study does not support a role of secondary hyperparathyroidism and subsequent PAC as the etiology of PH in patients with CRF.

Key Words: chronic renal failure • parathyroid hormone • pulmonary calcifications • pulmonary hypertension






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.